Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Med.

Sec. Nuclear Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1643850

This article is part of the Research TopicRecent developments in artificial intelligence and radiomicsView all 7 articles

Research progress in artificial intelligence for brain metastases

Provisionally accepted
Dongxiang  WangDongxiang Wang1Wei  WangWei Wang2Chenqi  LiangChenqi Liang1Tong  LiTong Li3*
  • 1Shandong First Medical University - Tai'an Campus, Tai'an, China
  • 2Shandong First Medical University, Jinan, China
  • 3Shandong Provincial Hospital, Jinan, China

The final, formatted version of the article will be published soon.

As artificial intelligence (AI) continues to evolve, its integration into medical practice is becoming increasingly prominent, particularly in the field of neuro-oncology. This review examines the application of AI—specifically machine learning (ML) and deep learning (DL)—in the imaging evaluation of brain metastases (BM). A systematic search of PubMed was conducted to identify relevant studies published within the past five years. The retrieved literature was categorized and analyzed according to three key clinical tasks: segmentation, differential diagnosis, and prognostic prediction.We first outline the capabilities of AI in the automatic detection and segmentation of BM using advanced imaging techniques. Subsequently, we synthesize evidence on how AI aids in distinguishing BM from other intracranial structures and lesions. Finally, we discuss the emerging role of AI in predicting disease prognosis and the development of new metastatic abnormalities.Current evidence suggests that AI not only enhances diagnostic efficiency and reproducibility but also provides clinically meaningful insights that support personalized treatment planning. Importantly, the integration of AI into neuro-oncological imaging remains at a nascent stage, indicating substantial potential for future growth and refinement in both technical performance and clinical applicability.

Keywords: brain metastases, MRI, deep learning, machine learning, CT

Received: 09 Jun 2025; Accepted: 05 Sep 2025.

Copyright: © 2025 Wang, Wang, Liang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Tong Li, Shandong Provincial Hospital, Jinan, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.